These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 36607480)
1. Delivery of curcumin within emulsome nanoparticles enhances the anti-cancer activity in androgen-dependent prostate cancer cell. Bolat ZB; Islek Z; Sahin F; Ucisik MH Mol Biol Rep; 2023 Mar; 50(3):2531-2543. PubMed ID: 36607480 [TBL] [Abstract][Full Text] [Related]
2. Characterization of CurcuEmulsomes: nanoformulation for enhanced solubility and delivery of curcumin. Ucisik MH; Küpcü S; Schuster B; Sleytr UB J Nanobiotechnology; 2013 Dec; 11():37. PubMed ID: 24314310 [TBL] [Abstract][Full Text] [Related]
3. Curcumin- and Piperine-Loaded Emulsomes as Combinational Treatment Approach Enhance the Anticancer Activity of Curcumin on HCT116 Colorectal Cancer Model. Bolat ZB; Islek Z; Demir BN; Yilmaz EN; Sahin F; Ucisik MH Front Bioeng Biotechnol; 2020; 8():50. PubMed ID: 32117930 [TBL] [Abstract][Full Text] [Related]
4. Modulation of AKR1C2 by curcumin decreases testosterone production in prostate cancer. Ide H; Lu Y; Noguchi T; Muto S; Okada H; Kawato S; Horie S Cancer Sci; 2018 Apr; 109(4):1230-1238. PubMed ID: 29369461 [TBL] [Abstract][Full Text] [Related]
5. 6-(3,4-Dihydro-1H-isoquinoline-2-yl)-N-(6-methoxypyridine-2-yl) nicotinamide-26 (DIMN-26) decreases cell proliferation by induction of apoptosis and downregulation of androgen receptor signaling in human prostate cancer cells. Choi HE; Shin JS; Leem DG; Kim SD; Cho WJ; Lee KT Chem Biol Interact; 2016 Dec; 260():196-207. PubMed ID: 27720946 [TBL] [Abstract][Full Text] [Related]
7. Curcumin induces cell cycle arrest and apoptosis of prostate cancer cells by regulating the expression of IkappaBalpha, c-Jun and androgen receptor. Guo H; Xu YM; Ye ZQ; Yu JH; Hu XY Pharmazie; 2013 Jun; 68(6):431-4. PubMed ID: 23875250 [TBL] [Abstract][Full Text] [Related]
8. Human prostate cancer cell epithelial-to-mesenchymal transition as a novel target of arsenic trioxide and curcumin therapeutic approach. Mirzaei A; Jahanshahi F; Khatami F; Reis LO; Aghamir SMK Tissue Cell; 2022 Jun; 76():101805. PubMed ID: 35487055 [TBL] [Abstract][Full Text] [Related]
9. Sensitization of androgen refractory prostate cancer cells to anti-androgens through re-expression of epigenetically repressed androgen receptor - Synergistic action of quercetin and curcumin. Sharma V; Kumar L; Mohanty SK; Maikhuri JP; Rajender S; Gupta G Mol Cell Endocrinol; 2016 Aug; 431():12-23. PubMed ID: 27132804 [TBL] [Abstract][Full Text] [Related]
10. [Curcumin-induced apoptosis in androgen-dependent prostate cancer cell line LNCaP in vitro]. Guo H; Yu JH; Chen K; Ye ZQ; Liu GC Zhonghua Nan Ke Xue; 2006 Feb; 12(2):141-4. PubMed ID: 16519151 [TBL] [Abstract][Full Text] [Related]
11. Antiproliferative, antiandrogenic and cytotoxic effects of novel caffeic acid derivatives in LNCaP human androgen-dependent prostate cancer cells. Sanderson JT; Clabault H; Patton C; Lassalle-Claux G; Jean-François J; Paré AF; Hébert MJ; Surette ME; Touaibia M Bioorg Med Chem; 2013 Nov; 21(22):7182-93. PubMed ID: 24080105 [TBL] [Abstract][Full Text] [Related]
12. mTOR is a fine tuning molecule in CDK inhibitors-induced distinct cell death mechanisms via PI3K/AKT/mTOR signaling axis in prostate cancer cells. Berrak O; Arisan ED; Obakan-Yerlikaya P; Coker-Gürkan A; Palavan-Unsal N Apoptosis; 2016 Oct; 21(10):1158-78. PubMed ID: 27484210 [TBL] [Abstract][Full Text] [Related]
13. Curcumin-Gene Expression Response in Hormone Dependent and Independent Metastatic Prostate Cancer Cells. Katta S; Srivastava A; Thangapazham RL; Rosner IL; Cullen J; Li H; Sharad S Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31581661 [TBL] [Abstract][Full Text] [Related]
14. Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens. Waltering KK; Helenius MA; Sahu B; Manni V; Linja MJ; Jänne OA; Visakorpi T Cancer Res; 2009 Oct; 69(20):8141-9. PubMed ID: 19808968 [TBL] [Abstract][Full Text] [Related]
15. Curcumin analogues with high activity for inhibiting human prostate cancer cell growth and androgen receptor activation. Zhou DY; Ding N; Du ZY; Cui XX; Wang H; Wei XC; Conney AH; Zhang K; Zheng X Mol Med Rep; 2014 Sep; 10(3):1315-22. PubMed ID: 25060817 [TBL] [Abstract][Full Text] [Related]
16. Growth inhibition of androgen-responsive prostate cancer cells with brefeldin A targeting cell cycle and androgen receptor. Rajamahanty S; Alonzo C; Aynehchi S; Choudhury M; Konno S J Biomed Sci; 2010 Jan; 17(1):5. PubMed ID: 20102617 [TBL] [Abstract][Full Text] [Related]
17. [Curcumin-induced the expression of inhibitor kappaBalpha protein in human prostate cancer cells]. Guo H; Yu JH; Chen K; Ye ZQ Zhonghua Wai Ke Za Zhi; 2006 Sep; 44(18):1256-9. PubMed ID: 17147887 [TBL] [Abstract][Full Text] [Related]
18. Linkage of curcumin-induced cell cycle arrest and apoptosis by cyclin-dependent kinase inhibitor p21(/WAF1/CIP1). Srivastava RK; Chen Q; Siddiqui I; Sarva K; Shankar S Cell Cycle; 2007 Dec; 6(23):2953-61. PubMed ID: 18156803 [TBL] [Abstract][Full Text] [Related]
19. Curcumin downregulates homeobox gene NKX3.1 in prostate cancer cell LNCaP. Zhang HN; Yu CX; Zhang PJ; Chen WW; Jiang AL; Kong F; Deng JT; Zhang JY; Young CY Acta Pharmacol Sin; 2007 Mar; 28(3):423-30. PubMed ID: 17303007 [TBL] [Abstract][Full Text] [Related]
20. Antitumor mechanism of combination of Angelica gigas and Torilis japonica in LNCaP prostate cancer cells via G1 arrest and inhibition of Wnt/β-catenin and androgen receptor signaling. Kim DH; Im E; Lee DY; Lee HJ; Sim DY; Park JE; Ahn CH; Koo JI; Pak JN; Kim SH Phytother Res; 2022 Jul; 36(7):2999-3008. PubMed ID: 35634973 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]